| Amanda S Brock, ANP | |
|
1215 Sidney St, Suite 202, Batesville, AR 72501-7203 | |
| (870) 262-2000 | |
| Not Available |
| Full Name | Amanda S Brock |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 15 Years |
| Location | 1215 Sidney St, Batesville, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336462712 | NPI | - | NPPES |
| A03334ANP | Other | AR | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LW0102X | Nurse Practitioner - Women's Health | A03334ANP (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| White River Medical Center | Batesville, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| White River Health System Inc | 0143134270 | 150 |
News Archive
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reported selected financial results for the fiscal quarter ended March 31, 2010 and provided a progress update of the Company's ANCHOR and MARINE trials, the two pivotal Phase 3 clinical trials of its lead product candidate AMR101 for treating elevated triglyceride levels.
A system developed by investigators at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine allowed successful transplantation of rat livers after preservation for as long as four days, more than tripling the length of time organs currently can be preserved.
XTend Medical, a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following information regarding the BioHarp market potential.
Data reported by the Hearts Beat Back: The Heart of New Ulm Project reinforce the positive influence of lifestyle factors in mitigating risks that potentially increase the likelihood of heart disease and other health problems. Findings based on 1,059 residents of New Ulm, Minn, underscore the importance of obesity prevention and nutrition, specifically eating more fruits and vegetables, in addressing metabolic syndrome, a common precursor to cardiovascular disease.
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
› Verified 4 days ago
| Entity Name | White River Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851470371 PECOS PAC ID: 0143134270 Enrollment ID: O20070228000020 |
News Archive
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reported selected financial results for the fiscal quarter ended March 31, 2010 and provided a progress update of the Company's ANCHOR and MARINE trials, the two pivotal Phase 3 clinical trials of its lead product candidate AMR101 for treating elevated triglyceride levels.
A system developed by investigators at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine allowed successful transplantation of rat livers after preservation for as long as four days, more than tripling the length of time organs currently can be preserved.
XTend Medical, a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following information regarding the BioHarp market potential.
Data reported by the Hearts Beat Back: The Heart of New Ulm Project reinforce the positive influence of lifestyle factors in mitigating risks that potentially increase the likelihood of heart disease and other health problems. Findings based on 1,059 residents of New Ulm, Minn, underscore the importance of obesity prevention and nutrition, specifically eating more fruits and vegetables, in addressing metabolic syndrome, a common precursor to cardiovascular disease.
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda S Brock, ANP 1215 Sidney St, Suite 202, Batesville, AR 72501-7203 Ph: (870) 262-2000 | Amanda S Brock, ANP 1215 Sidney St, Suite 202, Batesville, AR 72501-7203 Ph: (870) 262-2000 |
News Archive
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reported selected financial results for the fiscal quarter ended March 31, 2010 and provided a progress update of the Company's ANCHOR and MARINE trials, the two pivotal Phase 3 clinical trials of its lead product candidate AMR101 for treating elevated triglyceride levels.
A system developed by investigators at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine allowed successful transplantation of rat livers after preservation for as long as four days, more than tripling the length of time organs currently can be preserved.
XTend Medical, a company specializing in manufacturing and distributing the latest in telemedicine and diagnostic devices, released the following information regarding the BioHarp market potential.
Data reported by the Hearts Beat Back: The Heart of New Ulm Project reinforce the positive influence of lifestyle factors in mitigating risks that potentially increase the likelihood of heart disease and other health problems. Findings based on 1,059 residents of New Ulm, Minn, underscore the importance of obesity prevention and nutrition, specifically eating more fruits and vegetables, in addressing metabolic syndrome, a common precursor to cardiovascular disease.
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
› Verified 4 days ago
Mr. Leroy Maupin Jr., APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 407 Virginia Dr, Batesville, AR 72501 Phone: 870-793-4200 Fax: 870-698-1353 | |
Angela Burleson, MS, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1215 Sidney St Ste 202, Batesville, AR 72501 Phone: 870-262-2000 | |
Rachel Jeannette Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 905 20th St Ste B, Batesville, AR 72501 Phone: 870-569-4942 Fax: 870-569-4943 | |
Mrs. Michelle Lee Hagen, ACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1200 Fax: 870-262-6199 | |
Cynthia Elaine Jackson, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3443 Harrison St, Batesville, AR 72501 Phone: 870-698-1635 Fax: 870-612-3389 | |
Brandy M Moore, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 255 Virginia Dr, Batesville, AR 72501 Phone: 870-793-4300 | |
Robin Kerr, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1215 Sidney St Ste 300, Batesville, AR 72501 Phone: 870-793-1126 Fax: 870-793-1180 |